These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21337836)

  • 1. "The challenge facing renal artery revascularization: what have we not proven and why we must"?
    Hynes BG; Margey R; Moran D; Ruggiero NJ; Kiernan TJ; Jaff MR
    Acta Chir Belg; 2010; 110(6):575-83. PubMed ID: 21337836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
    Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
    N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous transluminal revascularization for renal artery stenosis: Veterans Affairs Puget Sound Health Care System experience.
    Yutan E; Glickerman DJ; Caps MT; Hatsukami T; Harley JD; Kohler TR; Davies MG
    J Vasc Surg; 2001 Oct; 34(4):685-93. PubMed ID: 11668325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restenosis after stenting of atherosclerotic renal artery stenosis: is there a rationale for the use of drug-eluting stents?
    Zeller T; Rastan A; Rothenpieler U; Müller C
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):125-30. PubMed ID: 16755597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent outcomes after percutaneous therapy for symptomatic renal artery stenosis.
    Sivamurthy N; Surowiec SM; Culakova E; Rhodes JM; Lee D; Sternbach Y; Waldman DL; Green RM; Davies MG
    J Vasc Surg; 2004 Mar; 39(3):565-74. PubMed ID: 14981450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endovascular revascularization of renal artery stenosis in the solitary functioning kidney.
    Davies MG; Saad WE; Bismuth JX; Naoum JJ; Peden EK; Lumsden AB
    J Vasc Surg; 2009 Apr; 49(4):953-60. PubMed ID: 19217744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerotic renal artery stenosis and renal artery stenting: an evolving therapeutic option.
    Margey R; Hynes BG; Moran D; Kiernan TJ; Jaff MR
    Expert Rev Cardiovasc Ther; 2011 Oct; 9(10):1347-60. PubMed ID: 21985547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary stenting for atherosclerotic renal artery stenosis.
    Steichen O; Amar L; Plouin PF
    J Vasc Surg; 2010 Jun; 51(6):1574-1580.e1. PubMed ID: 20488331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year experience with renal artery in-stent stenosis.
    Stone PA; Campbell JE; Aburahma AF; Hamdan M; Broce M; Nanjundappa A; Bates MC
    J Vasc Surg; 2011 Apr; 53(4):1026-31. PubMed ID: 21215576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical review of indications for renal artery stenting: do randomized trials give the answer?
    Schwarzwälder U; Zeller T
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):251-6. PubMed ID: 19434748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of endoluminal reintervention for restenosis after percutaneous renal angioplasty and stenting.
    Davies MG; Saad WA; Bismuth JX; Peden EK; Naoum JJ; Lumsden AB
    J Vasc Surg; 2009 Apr; 49(4):946-52. PubMed ID: 19217748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous vascular interventions in renal artery diseases.
    Kolluri R; Goldstein JA; Rocha-Singh K
    Minerva Cardioangiol; 2006 Feb; 54(1):95-107. PubMed ID: 16467745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD).
    Balzer KM; Pfeiffer T; Rossbach S; Voiculescu A; Mödder U; Godehardt E; Sandmann W
    J Vasc Surg; 2009 Mar; 49(3):667-74; discussion 674-5. PubMed ID: 19135837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis.
    Kane GC; Xu N; Mistrik E; Roubicek T; Stanson AW; Garovic VD
    Nephrol Dial Transplant; 2010 Mar; 25(3):813-20. PubMed ID: 19666661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial.
    Jaff MR; Bates M; Sullivan T; Popma J; Gao X; Zaugg M; Verta P;
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):343-50. PubMed ID: 22511402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis comparing open surgical and endovascular treatment of atherosclerotic renal artery stenosis.
    Abela R; Ivanova S; Lidder S; Morris R; Hamilton G
    Eur J Vasc Endovasc Surg; 2009 Dec; 38(6):666-75. PubMed ID: 19726208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balloon-expandable covered stent therapy of complex endovascular pathology.
    Giles H; Lesar C; Erdoes L; Sprouse R; Myers S
    Ann Vasc Surg; 2008 Nov; 22(6):762-8. PubMed ID: 18922676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal artery stenting slows the rate of renal function decline.
    Arthurs Z; Starnes B; Cuadrado D; Sohn V; Cushner H; Andersen C
    J Vasc Surg; 2007 Apr; 45(4):726-31; discussion 731-2. PubMed ID: 17398382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the management of atherosclerotic renal artery disease.
    Fenstad ER; Kane GC
    Minerva Cardioangiol; 2009 Feb; 57(1):95-101. PubMed ID: 19202521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous revascularization of persistent renal artery in-stent restenosis.
    Patel PM; Eisenberg J; Islam MA; Maree AO; Rosenfield KA
    Vasc Med; 2009 Aug; 14(3):259-64. PubMed ID: 19651676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.